Showing results (621-630 of 670) with videos related to

Sort By:
Pageof 67
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophagesMohamed S Arredouani, Aiyappa Palecanda, Henry Koziel, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Neurobiology of Aging|December 23, 2011
Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficitCédric Desbène, Catherine Malaplate-Armand, Ihsen Youssef, et al.
Applied Optics|March 17, 2026
High-sensitivity nanometamaterial near-infrared biosensor for label-free early cancer detection via exosomal biomarkersMusa N Hamza, Mohammad Alibakhshikenari, Mohammad Tariqul Islam, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Evaluation of an Air Cleaning Device Equipped with Filtration and UV: Comparison of Removal Efficiency on Particulate Matter and Viable Airborne Bacteria in the Inlet and Treated AirPeiyang Li, Jacek A Koziel, Nubia Macedo, et al.
BMC Cell Biology|June 12, 2014
Phenotypic plasticity in normal breast derived epithelial cellsCandice A M Sauder, Jillian E Koziel, MiRan Choi, et al.
The Journal of Infectious Diseases|March 7, 2006
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis CChihiro Morishima, Stephen J Polyak, Ranjit Ray, et al.
Circulation Research|March 5, 2024
Characterization of Vascular Niche in Systemic Sclerosis by Spatial ProteomicsAleix Rius Rigau, Yi-Nan Li, Alexandru-Emil Matei, et al.
Biochimie|March 24, 2009
The essential role of lipids in Alzheimer's diseaseSabrina Florent-Béchard, Cédric Desbène, Pierre Garcia, et al.
The New England Journal of Medicine|July 30, 2004
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected personsRaymond T Chung, Janet Andersen, Paul Volberding, et al.
Pageof 67